Precocious Puberty Flashcards
PPP Etiology
CAH Ovarian cysts Autonomous (McCune-Albright, testotoxicosis) Exogenous hormones Severe primary hypothyroidism Adrenal/gonadal tumors
CPP Etiology
Idiopathic CNS lesions Hypothalamic hamartoma Tumors (neurofibroma, craniopharyngioma) Malformation (septo-optic dysplasia, hydrocephalus, arachnoid cyst) Infection (brain abscess, meningitis) Trauma (surgery, irradiation, injury)
Diagnostic clues
Slowly progressive/minimal changes likely benign
ANY CNS dysfunction can > CPP
Vaginal mucosa w/o estrogen: glistening red
Vaginal mucosa w/estrogen: pinkish, leukorrhea
Bone age: advanced unless changes were very rapid
CPP usually more rapid than normal puberty
CPP Diagnosis
Idiopathic CNS lesions: MRI any girl <5 and any boy - Hypothalamic hamartoma - Craniopharyngioma - Malformation (septo-optic dysplasia, hydrocephalus, arachnoid cyst) - Infection (brain abscess, meningitis) - Trauma (surgery, irradiation, injury) - Neurofibromatosis: pigmented lesions
PPP Diagnosis
CAH: androgenic changes (body hair/odor, acne, advanced bone age) predominate
Ovarian cysts: pelvic U/S (other ovarian tumors rare, cause masculinization)
McCune-Albright: pigmented lesions, polyostotic fibrous dysplasia
Exogenous hormones: history
Severe primary hypothyroidism: TFT’s, arrested growth and other sx
Adrenal Tumors: DHEA-S extremely elevated
Gonadal Tumors: imaging
(testotoxicosis)
CPP vs PPP
LH/FSH unreliable- can be normal d/t episodic secretion
GnRH Stim Test: brisk LH>FSH rise = CPP, no LH/FSH increase = immature HPG (PPP)
Estradiol, testosterone can support
CPP > testicular enlargement first
PP Treatment
GnRH Agonists
GnRH pulses stimulate LH/FSH every 90-120 minutes
GnRH >/< frequent suppresses LH/FSH
Agonist binds continuously, suppressing LH/FSH
Reversible on discontinuation
CPP Treatment
Resect tumors EXCEPT hypothalamic hamartoma: benign, acts as accessory hypothalamic tissue, just use GnRH agonist
PPP Treatment
Treat the cause
McCune-Albright, autonomous gonadal steroid production:
- ketoconazole (blocks androgen production)
- aromatase inhibitors (block androgen > estrogen conversion)
- spironolactone (anti-androgen)